Gram-negative septicemia in patients with hematologic malignancies
- PMID: 6368245
- DOI: 10.1016/0277-5379(84)90077-4
Gram-negative septicemia in patients with hematologic malignancies
Abstract
The clinical records of 66 consecutive episodes of Gram-negative bacteremia occurring in 60 patients with hematologic malignancies during a 66-month period were reviewed to assess the major prognostic factors. The bacteremia-related mortality was 53%. Overall, Pseudomonas aeruginosa (54%) and Escherichia coli (24%) were the predominant isolates (fatality rate 78 and 31% respectively). The majority of patients (58/66) were granulocytopenic (PMN less than 1000/microliters). Among the 18 patients whose circulating granulocytes increased by one log10 or to above 1000/mmc during therapy, the fatality rate was 39%, as opposed to 70% in the 40 patients without such an increase. Pneumonia-associated bacteremia (56%) had a high fatality rate (73%) compared to isolated bacteremias (27%). Septic shock and inappropriate antibiotic therapy accounted for the highest mortality. Our data suggest that Pseudomonas etiology, persistent neutropenia, associated pneumonia, septic shock and inappropriate antibiotic therapy account for a bad prognosis in Gram-negative bacteremia in hematologic malignancies.
Similar articles
-
[Bacterial septicemia in neutropenia patients].Ann Med Interne (Paris). 1983;134(7):629-35. Ann Med Interne (Paris). 1983. PMID: 6666900 French.
-
Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.Rev Infect Dis. 1988 May-Jun;10(3):629-35. doi: 10.1093/clinids/10.3.629. Rev Infect Dis. 1988. PMID: 3393785
-
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.Int J Infect Dis. 1998-1999 Winter;3(2):99-104. doi: 10.1016/s1201-9712(99)90017-6. Int J Infect Dis. 1998. PMID: 10225988
-
Fever and infection in leukemic patients: a study of 494 consecutive patients.Cancer. 1978 Apr;41(4):1610-22. doi: 10.1002/1097-0142(197804)41:4<1610::aid-cncr2820410452>3.0.co;2-b. Cancer. 1978. PMID: 346201 Review.
-
Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.Semin Hematol. 1974 Apr;11(2):141-202. Semin Hematol. 1974. PMID: 4212049 Review. No abstract available.
Cited by
-
[Septicemia in leukemia and malignant lymphoma. Incidence pathogens--causes].Klin Wochenschr. 1985 Sep 2;63(17):821-6. doi: 10.1007/BF01732287. Klin Wochenschr. 1985. PMID: 4057913 German.
-
Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.Infect Immun. 1994 Oct;62(10):4320-4. doi: 10.1128/iai.62.10.4320-4324.1994. Infect Immun. 1994. PMID: 7927690 Free PMC article.
-
Empiric treatment of infection during granulocytopenia: a comprehensive approach.Infection. 1989 Mar-Apr;17(2):59-64. doi: 10.1007/BF01646877. Infection. 1989. PMID: 2654018 Review. No abstract available.
-
Nosocomial septicemias due to methicillin-resistant staphylococcus aureus and Pseudomonas aeruginosa in a university hospital over a 12-year period--the same intractable infections.Infection. 1996 May-Jun;24(3):238-41. doi: 10.1007/BF01781100. Infection. 1996. PMID: 8811362
-
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.BMC Infect Dis. 2017 Jul 17;17(1):500. doi: 10.1186/s12879-017-2597-0. BMC Infect Dis. 2017. PMID: 28716109 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials